CII National Conference on “Vaccine Industry in India: Current Status and Future Prospects”, Hotel Hayat Regency, New Delhi

‍

Panacea Biotec Ensures limited availability of Life Saving Drug Cilamin 250 Capsule (D-Penicillamine IP 250 mg)

‍

Panacea Biotec Launches - TENEPAN, A Cost Effective product for the treatment of Type 2 Diabetes Mellitus (T2DM)

‍

Panacea Biotec Receives Prestigious Intellectual Property & Science Award “Top 50 Indian Innovators 2015”

‍

Panacea Biotec Launches - CABAPAN, A cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)

‍

Panacea Biotec Gets Pan American Health Organization (PAHO) order for supply of EasyFive-TT Vaccines worth USD 13.49 Million

‍

Panacea Biotec Announces Collaboration with a leading International Pharmaceutical Company

‍

Panacea Biotec Announces Collaboration with Rising Pharmaceuticals Inc.

‍

Panacea Biotec Announces Strategic Alliance with Apotex Inc.

‍

DCVMN International develop multiple initiatives to accelerate access to affordable high quality-vaccines

‍